ISSN 0974-3618 (Print) www.rjptonline.org
0974-360X (Online)
REVIEW ARTICLE
Lycopene as an antioxidant and its medicinal uses
Sahana.
K
I BDS, Saveetha Dental College, Chennai
*Corresponding
Author E-mail: Sahanakriti@gmail.com
ABSTRACT:
An antioxidant molecule inhibits the oxidation of
other molecules. Oxidation is a chemical reaction that
transfers electrons or hydrogen from a substance to an oxidizing
agent. Oxidation reactions can produce free radicle, which can
start chain reactions. When this reaction occurs in cell, it can
cause damage or death to the cell. Antioxidants terminate these chain reactions
by removing free radical intermediates, and inhibit other oxidation reactions.
They do this by being oxidized themselves, so antioxidants are
often reducing agents. The antioxidant effect include a considerable
reactive oxygen species scavenging activity, which allows lycopene to prevent
lipid per oxidation and DNA damage. It also induces enzymes of the cellular
antioxidant defense systems by activating the antioxidant response element
transcription system. The tetra terpene structure of lycopene with two
unconjugated bonds is easily attacked by electrophilic reagents resulting in
extreme poverty reactivity towards oxygen and free radicals. Lycopene is a
bright red carotene and carotenoids pigment found in tomatoes, carrots,
watermelons, papayas and other red fruits and vegetables. It reduces the risk
of cancers of many organs, retards growth of tumors and also has a
chemopreventive effect against diseases like cardiovascular disease,
osteoporosis, male infertility, protection against damage caused by ionizing
radiation and reduces negative effect on cancer radiotherapy.
KEY WORDS: Lycopene,
antioxidant, carotenoid, oxidation.
INTRODUCTION:
Group of molecules which are highly reactive towards
biomolecules and are derivatives of oxygen are called reactive oxygen species
(ROS). Oxidizing agents can be those which contain free radical in an atom or
molecule which contain one or more unpaired electrons and are more reactive
than non-radicals. These ROS can react with lipid, proteins and nucleic acid
causing oxidative stress and damage leading to pathogenesis of age related and
chronic diseases [1]. Defense from the damaging effect of ROS is provided by
the antioxidant which convert the oxidants into less reactive species [2]
Lycopene which is an acyclic isomer of beta carotene present in red pigmented
fruits like tomatoes, watermelons, pink grapes, apricots, pink guavas and
papayas is a strong antioxidant that decreases free radical attack on
biomolecules [3].
Received on 15.05.2015
Modified on 24.06.2015
Accepted on 20.07.2015 ©
RJPT All right reserved
Research J. Pharm. and Tech. 8(8): August,
2015; Page 1043-1047
DOI: 10.5958/0974-360X.2015.00178.X
It prevents generation of ROS and effectively combats
oxidative damage. It doesn’t have any vitamin A activity even though it is a
carotene. lycopene is an important intermediate
substance in the biosynthesis of many carotenoids, including beta carotene, which is responsible
for yellow, orange, or red pigmentation, photosynthesis, photo-protection and
food colouring.
Lycopene – Biochemistry:
Absorption of
carotenoids in human serum and tissue takes place but the intake of tomato and
tomato based food products. Tomatoes contain a red pigmented carotenoid –
lycopene. Lycopene is an acyclic isomer of beta- carotene. It is a highly
unsaturated hydrocarbon containing 11 conjugated bonds and 2 unconjugated
double bonds. It is a potent antioxidant with single- oxygen- quenching ability
[4] and when compared with beta-
carotene it is twice more potent and 10
times more potent than alpha- tocophenol. Its molecular weight is 536.89 and
molecular formula is C40H56 with 89.45% carbon and 10.51% hydrogen. It is
abundantly found in plants or autotrophic bacteria. Fruits and vegetables
containing red pigments like watermelons, pink grapes, apricots, pink guavas
and papayas also contains lycopene [5]. Absorption of lycopene in its natural
trans form is very poor [6]. Hence it undergoes isomerization to cis form. This
cis-trans isomerization can be induced through light, thermal and chemical
reactions [7]. Its absorption takes place in the GI tract and
transportation takes place from the
intestinal mucosa through the lymphatic system [9]. Lycopene is the most
predominant carotenoid in human plasma, adrenal gland, testes, liver and
prostrate [8]. It does not get involved in the synthesis mechanism of vitamin A
when compared with beta- carotene and
alpha- tocophenol, as it lacks beta-ionone ring structure [5]. Due to its high
lipophilic nature it is commonly located within the cell membrane and other
lipid components. Lycopene is insoluble in
water, and can be dissolved only in organic solvents and oils. Due to its non
polarity it stains porous materials easily and during oxidation, it eliminates
chromophore. In plants and microorganisms it serves as an accessory light
gathering pigment and provides protection against the toxic effect of oxygen
and light [9].
Structure
of LYCOPENE
Lycopene- Antioxidant:
Lycopene has an extensive ability to scavenge free
radicals in cell culture and in animal models [10]. By trapping the ROS, OH,
NO2, it leads to the oxidative breakdown of the lycopene molecule that protects
against in vivo oxidation of lipids, proteins and DNA [11]. It enhances
cellular antioxidant defense system by regenerating the non enzymatic
antioxidants for further action [12]. In a lipophilic environment it has
maximum scavenging effect on ROS and prevents its generation. In in vitro
conitions lycopene can inhibit oxidation of LDL [13]. In vitro evidence indicates that lycopene reduces cellular
proliferation which are potent mitogens in various cancer cell lines [14]. Its
inhibitory action on cell cycle progresses from the Go/G1 to S phase [9].
Activation of phase II detoxifying enzymes to modulate cell cycle and induction
of apoptosis on cancer cells at the transcriptional level [12]. Increased time
of tumor development and survival time was observed with pretreatment of
lycopene. It was noted that lycopene had the capacity to inhibit breast cancer
cell proliferation and, endometrial, lung cancer cell growth, arrest the cell
cycle at different phases, and apoptosis in cell cultures. Protection to the
intestinal toxicity is done by reducing lipid peroxidation and increased
antioxidant enzyme activity. By its
antioxidative property it gives protection against toxicity caused by
chemotherapeutic drugs that also have cytotoxic effect similar to radiation
[15]. There is a strong protection provided against DNA based oxidative damage
by neutralizing ROS and reducing susceptibility of lymphocytic DNA to the same
based on antioxidative status of
lycopene [16]. Its effect can be seen on DNA oxidative damage which is either
directly induced with the help of
hydrogen peroxide H2O2 or indirectly by n-nitrosodiethylamine (DEN) on models
used for identifying anti-mutagens. It was shown that it prevented DEN- induced
neoplasia as it prevented primary damage of DNA due to the exposure of DEN and
inhibits mutagenic and genotoxic effects due to exposure of H2O2 [12]. It
decreases benign prostate hyperplasia by increasing the apoptic cell death
[17]. Anti-proliferative and pro-apoptotic activity of the lycopene has been
observed in malignant T-lymphoblast cells. Exhibiton of anti-metastic activity
by the expression of metastasis suppressor gene in a hepatocarcinoma cell line.
Its action is via the mevalonte pathways [12]. It also acts as a
hypocholesterolenic agent by inhibiting HMG-CoA reductase pathway [18]. Gap
junctions are useful for the communication between the neighbouring cells and are
formed by connexin proteins. This communication are very important for the cell
growth and loss of the gap junction communication leads to carcinogenesis.
Evidences prove that this communication is chemically restored by lycopene and
inhibits carcinogenesis [12].
Figure 1. Schematic overview of the anti-oxidant,
anti-proliferative and anti-metastatic activities of lycopene and its cellular
targets as well as signaling pathways affected by this compound.
Figure 2: oxidative stress
Figure 3: antioxidative pathways
Figure4: action on DNA
Figure 5: Cellular damage.
Lycopene- Medicinal Uses:
Lycopene gave protection against myocardial infarction
risk in non-smokers [19] and also with a higher plasma concentration it was
associated to reduce the risk of cardio-vascular disease in women [20].
Hypothesis of lycopene improving endothelial fuction in patiets with preexisting
cardio-vascular disease [21]. By treating the cardio-vascular patients with
lycopene, reduction of blood pressure and improvement in Ach responses could be
observed [21]. Lower plasma concentrations were linked with increase in the
risk of atherosclerotic lesions. Studies
show that there is an extensive impact on the male infertility. Impotent males
genetically produce high levels of free radicals. By consuming 8mg/day of
lycopene supplements it was shown that in 50 volunteers with low sperm count,
70% showed improved sperm count, 60% showed functional sperm concentrations,
54% showed improved sperm motility, 46% had improved sperm motility index, and
38% had improved sperm morphology [22]. Dietary intake of carotenoids provide
protection from UV-induced erythema in humans [23]. According to the results of
author [24] it is shown that lycopene provides protection against methylmercury
(MeHG) which is a neurotoxin and also plays a role in preventing mitochondrial
dysfunction. Serum lycopene level showed inverse relation with the risk of
cervical intraepithelial neoplasia [25] as well as bladder cancer [26]. Low
lycopene concentrations in the skin is said to provide protection against UV
light stress but at higher concentrations it showed pro-oxidative effect [12].
Lycopene is said to show some beneficial effects in the treatment of oral
diseases like oral cancer and precancerous lesions [9]. Oral submucous fibrosis
(OSMF) is a premalignant condition characterized by progressive fibrosis of the
oral mucosa [21]. The curative effect of lycopene which is due to inhibition of
abnormal fibroblasts, regulates the lymphocyte resistance to stress and
suppression of inflammatory response. Leukoplakia is is the most common
precancerous lesion in the oral cavity with a recognizable risk for malignant
transformation. Tobacco usage generates increased reactive free radicals and
active oxygen species, which mediate phenotypic and genotypic alterations and
lead mutations to carcinogenesis. The serum levels of lycopene and B carotene
among men with oral leukoplakia were significantly lower than those of
controls. Tumor suppressor gene is p53, and mutations of this gene have been
observed in various sites of premalignant leukoplakia and carcinoma in the same
oral cavity. A reduction in tumor suppressor activity by the gene and the
development of mutations in p53 are associated with smoking and an increased
risk for oral carcinoma development. Lycopene has been reported to increase p53
protein levels in cancer cells [21].
Figure 6: Free radical
oxidative stress
LYCOPENE- ANIMAL TESTING:
Over the period of time there has been a lot of animal
models used to analyse the absorption, tissue distribution and effect of
lycopene. Concentration of lycopene is observed highest in liver,spleen and
prostrate and lowest in the brain of rats in a demonstration by Jain et al.[27]. To enhance the immune
response in mice, increase in T helper cells and normalizing intrathymic T cell
differentiation caused by tumor genesis was observed [28]. Small doses of
lycopene reduced N-methylnitrosourea (MNU) induced development of aberrant
crypt foci in the Sprague-Dawley rats was seen by the author [29]. In vitro
study of bone marrow prepared from rat femurs demonstrated that in the presence
or absence of parathyroid hormone (PTH) lycopene inhibited osteoclastc activity
of mineral resorption and formation of tartrate resistant acid phosphatase (TRAP)
[30]. Laboratory demonstrations of protection against azoxymethane (AOM)
induced by colonic preneoplastic lesions was noted [26]. Gluthatione oxidation
was seen in adult rats due to its effect on Sertoli cells [31]. The expression
of NQO1 in rats which increased mRNA and protein levels was seen due to the
administration of lycopene. This subsequently was able to improve nephrotoxic
phenotype which occurred due to chemotherapeutic treatment for solid tumors
[12].
CONCLUSION:
Lycopene being an very effective and strong
antioxidant helps not only in free radical scavenging but also plays a major
role in reducing the risk of cancers of various organs. The availability of it
is abundant in nature and hence the dietary supplementation of it is vast. Its
influence can be observed even over other diseases such as the cardiovascular
disease, osteoporosis male infertility, mitochondrial dysfunction. At low
concentrations it even provides protection against UV induced erythema. By its
supplementation for cancer radiotherapy, the side effects can be reduced due
the chemopreventive property of it. There were a lot of trails done on the
effect of lycopene on various conditions stimulated in the animal. The
restoration of gap junction communication helps in the prevention of
carcinogenesis. Its anti-inflammatory property also remarkably constitutes to
the anti- cancer potential and age-related muscular degeneration.
REFERENCE:
1 Agarwal A.,
Shen H., Agarwal S., Rao A.V.: Lycopene content of tomato products: its
stability, bioavailability and in vivo antioxidant properties. J Med Food.
2001; 4: 9-15.
2 Sies H.: Oxidative stress: oxidants and antioxidants. Exp
Physiol. 1997, 82: 291–295.
3 El-Habit O.H.M., Saada H.N., Azab K.H.S.H., Abdel-Rahman M.,
El-Malah D.F.: The modifying effect of β-carotene on gamma radiation
induced elevation of oxidative reactions and genotoxicity in male rats. Mutat
Res. 2000; 466: 179-86.
4 Di Mascio P., Kaiser S., Sies H.: Lycopene as the most
effective biological carotenoid singlet oxygen quencher. Arch Biochem Biophys.
1989; 274: 532-8.
5 Stahl W., Sies H.: Lycopene: a biologically important
carotenoid for humans? Arch Biochem Biophys. 1996; 336: 1-9
6 Rao A.V, Agarwal S.: Role of antioxidant lycopene in
cancerand heart disease. J Am Coll Nutr. 2000; 19: 563- 69.
7 Nguyen M.L., Schwartz S.J.: Lycopene: chemical and biological
properties. Food Technol. 1999; 53: 38-45.
8 Kaplan L.A., Lau J.M., Stein E.A.: Carotenoid composition,
concentrations and relationships in various human organs. Clin Physiol Biochem.
1990; 8 (1): 1-10.
9 Mehta. D.N: Lycopene: Structure, Pharmacokinetics and Role in
Oral Cancer- Precancerous Lesions. Journal of Research and advancement in
Dentistry, Vol.1No.2, March-June 2012: 44-49.
10 Levy J., Bosin E., Feldmen B., Giat Y., Miinster A., Danilenko
M., Sharoni Y.: Lycopene is a more potent inhibitor of human cancer cell
proliferation than either α carotene or β-carotene. Nutr Cancer.
1995; 24: 257-66.
11 Stahl W., Sies H.: Antioxidant activity of carotenoids. Mol.
Aspects Med. 2003; 24: 345-51.
12 KELKEL M , SCHUMACHER M ,
DICATO M and DIEDERICH M: Antioxidant and anti-proliferative properties
of lycopene. Free Radical Research, August 2011; 45 (8): 925–940
13 Esterbauer H, Gebicki J, Puhl H, Jurgens G: The role of lipi
peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol
Med 13:341–390, 1992.
14 Levy J, Bosin E, Feldmen B, Giat Y, Miinster A, Danilenko M,
Sharoni Y: Lycopene is a more potent inhibitor of human cancer cell
proliferation than either a-carotene or b-carotene. Nutr Cancer 24:257–266,
1995.
15 Atessahin A., Yilmaz S., Karahan I., Ceribasi A.O., Karaoglu
A.: Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative
stress in rats. Toxicology. 2005; 212: 116-23.
16 Riso P., Pinder A., Santangelo A., Porini M.: Does tomato
consumption effectively increase the resistance of lymphocyte DNA to oxidative
damage? Am J Clin Nutr. 1999; 69: 712-18.
17 Khan N,
Adhami VM, Mukhtar H: Apoptosis by dietary agents for prevention and treatment
of prostate cancer. Endocr Relat Cancer. 2010 March:1-20
18 Fuhramn B, Elis A, Aviram M: Hypocholesterolemic effect of
lycopene and b-carotene is related to suppression of cholesterol synthesis and
augmentation of LDL receptor activity in macrophage. Biochem Biophys Res Commun
233:658–662, 1997.
19 Kohlmeir L., Kark J.D., Gomez-Gracia E., Martin B.C., Steck
S.E., Kardinaal A.F., Ringstad J., Thamm M., Masaev V., Riemersma R.,
Martin-Moreno J.M., Huttunen J.K., Kok F.J.: Lycopene and myocardial infarction
risk in the EURAMIC Study. Am J Epidemiol. 1997; 146 (8): 618-26.
20 Diplock A.T., Charleux J.L., Crozier-Willi G., Kok F.J.,
Rice-Evans C., Roberfroid M., Stahl W., Vina-Ribes J.: Functional food science
and defense against reactive oxidative species. Br J Nutr. 1998; 80 (suppl 1):
S77-112.
21 Gajendragadkar PR, Hubsch
A, Ma¨ ki-Peta¨ ja¨KM , Serg M, Wilkinson IB, Cheriyan J:Effects of Oral
Lycopene Supplementation on Vascular Function in Patients with Cardiovascular
Disease and Healthy Volunteers: A Randomised Controlled Trial. PLOS ONE. June
2014; Volume 9; Issue 6; e99070:1-13.
22 Mohanty N.K., Sujit K., Jha A.K., Arora R.P.: Management of
idiopathic oligoasthenospermia with lycopene. Ind J Urol. 2001; 18(1): 57-61.
23 Stahl W., Heinrich U., Wiseman S., Eichler O., Sies H., Tronnier
H.: Dietary tomato paste protects against ultraviolet light-induced erythema
in humans. J. Nutr. 2001; 131: 1449-51.
24 Qu M., Nan X., Gao Z., Liu B., Chen Z.: Protective effects of
lycopene against methylmercury-induced neurotoxicity in cultured rat
cerebellar granule neurons. Brain Res. 2013; 1540: 92-102.
25 VanEewyck J, Davis FG, Bowen PE: Dietary and serum carotenoids
and cervical intraepithelial neoplasia. Int J Cancer 48:34–38, 1991.
26 Helzlsouer KJ, Comstock GW, Morris JS: Selenium, lycopene,
a-tocopherol, b-carotene, retinol, and subsequent bladder cancer. Cancer Res
49:6144–6148, 1989.
27 Jain CK, Agarwal S, Rao AV: The effect of dietary lycopene on
bioavailability, tissue distribution, in-vivo antioxidant properties and
colonic preneoplasia in rats. Nutr Res 19:1383–1391, 1999.
28 Kobayashi T, Iijima K, Mitamura T, Toriizuka K, Cyong JC,
Nagasawa H: Effects of lycopene, a carotenoid, on intrathymic T cell
differentian and peripheral CD4/CD8 ratio in a high mammary tumor strain of SHN
retired mice. Anti-Cancer Drugs 7:195–198, 1996.
29 Narisawa T, Fukaura Y, Hasebe M, Nomura S, Oshima S, Sakamoto H,
Inakuma T, Ishiguro Y, Takayasu J, Nishino H: Prevention of
N-methylnitrosourea-induced colon carcinogenesis in F344 rats by lycopene. Jpn J
Cancer Res 89:1003–1008, 1998.
30 Rao L.G., Krishnadev N., Banasikowska K., Rao A.V.: Lycopene
I-effect on osteoclasts: lycopene inhibits basal and parathyroid
hormone-stimulated osteoclast formation and mineral resorption mediated by
reactive oxygen species in rat bone marrow cultures. J Med Food. 2003; 6:
69-78.
31 Krishnamoorthy. G, Selvakumar. K, Venkataraman. P, Elumalai. P, Arunakaran.
J.: Lycopene supplementation prevents reactive oxygen species mediated
apoptosis in Sertoli cells of adult albino rats exposed to polychlorinated
biphenyls. SETOX and Institute of Experimental Pharmacology and Toxicology,
2013; Vol.6 (2): 83-92